“…Methylated purine, pyrimidine and other modified nucleosides have been shown to be excreted in abnormal amounts in urine of patients with cancer (Watanabe and Maekawa, 2010;Hatziapostolou and Iliopoulos, 2011). Elevated concentrations have been suggested as possible markers of different forms and stages cancers (Hsu et al, 2011;Vareed et al, 2011;Markuszewski et al, 2010;Struck et al, 2011;Krattiger et al, 1995;Masuda et al, 1993) It was concluded that the levels of nucleosides in urine from cancer patients were, generally, elevated, and that the increase in modified nucleosides was more pronounced than that of normal nucleosides. In addition, the concentrations of pseudouridine (pseu), 1-methylinosine (m1I), N4-acetylcytidine (ac4C), 1-methylguanosine (m1G) and 2-methyl guanosine (m2G) in urine of cancer patients were elevated significantly.…”